BIMPROV Trademark

Trademark Overview


On Friday, October 25, 2013, a trademark application was filed for BIMPROV with the United States Patent and Trademark Office. The USPTO has given the BIMPROV trademark a serial number of 86101711. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 29, 2023. This trademark is owned by Glaxo Group Limited. The BIMPROV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardio...
bimprov

General Information


Serial Number86101711
Word MarkBIMPROV
Filing DateFriday, October 25, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 29, 2023
Registration Number5220614
Registration DateTuesday, June 13, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2014

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "BIMPROV" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, December 29, 2023CANCELLED SEC. 8 (6-YR)
Monday, August 1, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 1, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, August 1, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 1, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 13, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 13, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, May 10, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, April 12, 2017NOTICE OF ALLOWANCE CANCELLED
Wednesday, April 12, 2017TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, September 28, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 27, 2016SOU EXTENSION 5 GRANTED
Monday, September 12, 2016SOU EXTENSION 5 FILED
Monday, September 12, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, April 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 19, 2016SOU EXTENSION 4 GRANTED
Wednesday, March 16, 2016SOU EXTENSION 4 FILED
Wednesday, March 16, 2016SOU TEAS EXTENSION RECEIVED
Friday, September 18, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 17, 2015SOU EXTENSION 3 GRANTED
Tuesday, September 8, 2015SOU EXTENSION 3 FILED
Thursday, September 17, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 8, 2015SOU TEAS EXTENSION RECEIVED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, May 2, 2015SOU EXTENSION 2 GRANTED
Thursday, March 26, 2015SOU EXTENSION 2 FILED
Saturday, May 2, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 26, 2015SOU TEAS EXTENSION RECEIVED
Thursday, October 2, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 30, 2014SOU EXTENSION 1 GRANTED
Tuesday, September 30, 2014SOU EXTENSION 1 FILED
Tuesday, September 30, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, April 15, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 18, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 29, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 11, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 10, 2014ASSIGNED TO EXAMINER
Friday, November 1, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 29, 2013NEW APPLICATION ENTERED